CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +905 | $38.10 | $34K | 104,806 |
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −905 | $61.21 | $55K | 103,901 |
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −22,661 | 8,675 | ||
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,019 | 7,656 | ||
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −905 | 6,751 | ||
| 2025-09-11 | Reeve Emma Director | Sale 10b5-1 | −3,534 | $59.50 | $210K | 11,666 |
| 2025-09-11 | Reeve Emma Director | Sale 10b5-1 | −1,334 | $59.50 | $79K | 10,332 |
| 2025-09-11 | Reeve Emma Director | Option exercise 10b5-1 | +10,000 | $25.69 | $257K | 20,332 |
| 2025-09-11 | Reeve Emma Director | Sale 10b5-1 | −10,000 | $59.50 | $595K | 10,332 |
| 2025-09-11 | Reeve Emma Director | Option exercise 10b5-1 | +837 | $33.63 | $28K | 11,169 |
| 2025-09-11 | Reeve Emma Director | Sale 10b5-1 | −837 | $59.50 | $50K | 10,332 |
| 2025-09-11 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2025-09-11 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −837 | 0 | ||
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +17,838 | $38.10 | $680K | 121,739 |
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −17,838 | $61.00 | $1.1M | 103,901 |
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +2,356 | $38.10 | $90K | 106,257 |
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −2,356 | $61.00 | $144K | 103,901 |
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +2,470 | $38.10 | $94K | 106,371 |
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −2,470 | $61.00 | $151K | 103,901 |
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,838 | 36,162 |
Page 23 of 25 · 493 trades